Co-Diagnostics - Codx.O (CODX)

- 02/2/2020 14:30
rampani N° messaggi: 72895 - Iscritto da: 03/9/2007
Grafico Intraday: Co Diagnostics IncGrafico Storico: Co Diagnostics Inc
Grafico IntradayGrafico Storico

Co-Diagnostics, Inc. is a molecular diagnostics company. The Company is engaged in developing, manufacturing and marketing diagnostics technology. Its reagents are used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules, such as deoxyribonucleic acid and ribonucleic acid. It also sells diagnostic equipment from other manufacturers as self-contained lab systems (MDx device). The Company uses its proprietary test design system and proprietary reagents to design and sell polymerase chain reaction diagnostic tests for diseases and pathogens starting with tests for tuberculosis, a drug resistant tuberculosis test, hepatitis B and C, Malaria, dengue, human immunodeficiency virus and Zika virus, all of which tests have been designed and validated in its laboratory. Its diagnostics systems enable molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.



Lista Commenti
41 Commenti
  3
MODERATO aalberto1 (Utente disabilitato) N° messaggi: 8345 - Iscritto da: 16/1/2020
41 Commenti
  3
Titoli Discussi
NASDAQ:CODX 1.21 0.8%
Co Diagnostics Inc
Co Diagnostics Inc
Co Diagnostics Inc
Indici Internazionali
Australia 0.4%
Brazil 1.1%
Canada 0.6%
France 0.5%
Germany 0.5%
Greece 0.1%
Holland 1.0%
Italy -0.3%
Portugal -0.3%
US (DowJones) 1.2%
US (NASDAQ) 2.0%
United Kingdom 0.5%
Rialzo (%)
BIT:WSIAV 0.05 25.0%
BIT:MPT 0.27 19.8%
BIT:AUTME 2.60 18.2%
BIT:1PLUG 2.52 14.7%
BIT:1AMGN 292 12.7%
BIT:WTWL24 0.45 11.9%
BIT:EPH 0.00 11.1%
BIT:1SQ 70.46 10.0%
BIT:WFCH25 1.21 10.0%
BIT:1CVAC 2.58 9.8%

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network